nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—CYP2D6—Methimazole—Graves' disease	0.569	1	CbGbCtD
Hydroxychloroquine—Pigmentation disorder—Methimazole—Graves' disease	0.0676	0.162	CcSEcCtD
Hydroxychloroquine—Pigmentation disorder—Propylthiouracil—Graves' disease	0.0575	0.137	CcSEcCtD
Hydroxychloroquine—Aplastic anaemia—Methimazole—Graves' disease	0.0212	0.0507	CcSEcCtD
Hydroxychloroquine—Aplastic anaemia—Propylthiouracil—Graves' disease	0.018	0.0431	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Propylthiouracil—Graves' disease	0.0148	0.0353	CcSEcCtD
Hydroxychloroquine—Drowsiness—Methimazole—Graves' disease	0.0126	0.0302	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Methimazole—Graves' disease	0.0118	0.0282	CcSEcCtD
Hydroxychloroquine—Chloroquine—TNF—Graves' disease	0.0114	1	CrCbGaD
Hydroxychloroquine—Drowsiness—Propylthiouracil—Graves' disease	0.0107	0.0257	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Propylthiouracil—Graves' disease	0.01	0.024	CcSEcCtD
Hydroxychloroquine—Alopecia—Methimazole—Graves' disease	0.01	0.024	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Propylthiouracil—Graves' disease	0.00969	0.0232	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Propylthiouracil—Graves' disease	0.00964	0.023	CcSEcCtD
Hydroxychloroquine—Vertigo—Methimazole—Graves' disease	0.00887	0.0212	CcSEcCtD
Hydroxychloroquine—Leukopenia—Methimazole—Graves' disease	0.00884	0.0211	CcSEcCtD
Hydroxychloroquine—Alopecia—Propylthiouracil—Graves' disease	0.00852	0.0204	CcSEcCtD
Hydroxychloroquine—Oedema—Methimazole—Graves' disease	0.00806	0.0193	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Methimazole—Graves' disease	0.00789	0.0189	CcSEcCtD
Hydroxychloroquine—Vertigo—Propylthiouracil—Graves' disease	0.00754	0.018	CcSEcCtD
Hydroxychloroquine—Leukopenia—Propylthiouracil—Graves' disease	0.00751	0.018	CcSEcCtD
Hydroxychloroquine—Somnolence—Methimazole—Graves' disease	0.00716	0.0171	CcSEcCtD
Hydroxychloroquine—Oedema—Propylthiouracil—Graves' disease	0.00685	0.0164	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00671	0.016	CcSEcCtD
Hydroxychloroquine—Urticaria—Methimazole—Graves' disease	0.0064	0.0153	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Methimazole—Graves' disease	0.00637	0.0152	CcSEcCtD
Hydroxychloroquine—Somnolence—Propylthiouracil—Graves' disease	0.00609	0.0146	CcSEcCtD
Hydroxychloroquine—Pruritus—Methimazole—Graves' disease	0.0057	0.0136	CcSEcCtD
Hydroxychloroquine—Urticaria—Propylthiouracil—Graves' disease	0.00544	0.013	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Propylthiouracil—Graves' disease	0.00541	0.0129	CcSEcCtD
Hydroxychloroquine—Vomiting—Methimazole—Graves' disease	0.00512	0.0122	CcSEcCtD
Hydroxychloroquine—Rash—Methimazole—Graves' disease	0.00508	0.0121	CcSEcCtD
Hydroxychloroquine—Dermatitis—Methimazole—Graves' disease	0.00507	0.0121	CcSEcCtD
Hydroxychloroquine—Headache—Methimazole—Graves' disease	0.00505	0.0121	CcSEcCtD
Hydroxychloroquine—Pruritus—Propylthiouracil—Graves' disease	0.00485	0.0116	CcSEcCtD
Hydroxychloroquine—Nausea—Methimazole—Graves' disease	0.00479	0.0114	CcSEcCtD
Hydroxychloroquine—Vomiting—Propylthiouracil—Graves' disease	0.00436	0.0104	CcSEcCtD
Hydroxychloroquine—Rash—Propylthiouracil—Graves' disease	0.00432	0.0103	CcSEcCtD
Hydroxychloroquine—Dermatitis—Propylthiouracil—Graves' disease	0.00431	0.0103	CcSEcCtD
Hydroxychloroquine—Headache—Propylthiouracil—Graves' disease	0.00429	0.0103	CcSEcCtD
Hydroxychloroquine—Nausea—Propylthiouracil—Graves' disease	0.00407	0.00973	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—CD40—Graves' disease	0.000126	0.0781	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—CXCL10—Graves' disease	0.000113	0.0698	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—CD40—Graves' disease	9.99e-05	0.0617	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—CD40—Graves' disease	9.86e-05	0.0609	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—CXCL10—Graves' disease	8.92e-05	0.0552	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—CXCL10—Graves' disease	8.81e-05	0.0545	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—CD40—Graves' disease	7.8e-05	0.0482	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—CXCL10—Graves' disease	6.97e-05	0.0431	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—IL1B—Graves' disease	5.08e-05	0.0314	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IFIH1—Graves' disease	4.11e-05	0.0254	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL1B—Graves' disease	4.01e-05	0.0248	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	3.96e-05	0.0245	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	3.68e-05	0.0228	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IFIH1—Graves' disease	3.25e-05	0.0201	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—HLA-E—Graves' disease	3.23e-05	0.02	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	3.13e-05	0.0194	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	2.91e-05	0.018	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	2.88e-05	0.0178	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—HLA-E—Graves' disease	2.55e-05	0.0158	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IFIH1—Graves' disease	2.39e-05	0.0148	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—HLA-B—Graves' disease	2.3e-05	0.0142	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	2.27e-05	0.0141	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IFIH1—Graves' disease	1.89e-05	0.0117	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HLA-E—Graves' disease	1.88e-05	0.0116	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD40—Graves' disease	1.84e-05	0.0114	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—HLA-B—Graves' disease	1.82e-05	0.0112	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CTLA4—Graves' disease	1.81e-05	0.0112	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HLA-DQB1—Graves' disease	1.49e-05	0.00923	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HLA-E—Graves' disease	1.49e-05	0.00919	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD40—Graves' disease	1.45e-05	0.00899	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CTLA4—Graves' disease	1.43e-05	0.00886	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD8A—Graves' disease	1.39e-05	0.00861	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CD4—Graves' disease	1.37e-05	0.0085	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HLA-B—Graves' disease	1.34e-05	0.00829	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TSHR—Graves' disease	1.3e-05	0.00804	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL2RA—Graves' disease	1.26e-05	0.00777	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HLA-A—Graves' disease	1.24e-05	0.00768	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HLA-DQB1—Graves' disease	1.18e-05	0.00729	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HLA-DRB1—Graves' disease	1.14e-05	0.00702	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD8A—Graves' disease	1.1e-05	0.00681	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ICAM1—Graves' disease	1.09e-05	0.00673	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CD4—Graves' disease	1.09e-05	0.00672	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HLA-B—Graves' disease	1.06e-05	0.00655	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL2RA—Graves' disease	9.93e-06	0.00614	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HLA-A—Graves' disease	9.82e-06	0.00607	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HLA-DRB1—Graves' disease	8.97e-06	0.00555	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ICAM1—Graves' disease	8.61e-06	0.00532	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CXCL10—Graves' disease	8.4e-06	0.00519	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IFNG—Graves' disease	8.29e-06	0.00512	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD4—Graves' disease	8.01e-06	0.00495	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL1B—Graves' disease	7.39e-06	0.00457	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IFNG—Graves' disease	6.55e-06	0.00405	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL2RA—Graves' disease	6.42e-06	0.00397	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD4—Graves' disease	6.33e-06	0.00391	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL1B—Graves' disease	5.84e-06	0.00361	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GC—Graves' disease	3.72e-06	0.0023	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—B3GNT2—Graves' disease	2.82e-06	0.00174	CbGpPWpGaD
